Analyte detection on a solid support by nucleic acid amplification coupled to an immunoassay

Patent metadata

Field	Value
Publication number	US-11008604-B2
Application number	US-201515529597-A
Country	US
Kind code	B2
Filing date	Dec 8, 2015
Priority date	Dec 18, 2014
Publication date	May 18, 2021
Grant date	May 18, 2021

Abstract

Embodiments of the invention provides a method for detection of at least one analyte derived from a sample, comprising the steps of: a) depositing the sample on a surface of a solid support; b) transferring at least a portion of the solid support to a receptacle suitable for performing a specific binding assay for one or more analytes of interest; c) optionally washing the portion; d) adding a single specific binding partner for each analyte of interest to the receptacle, the binding partner being labelled with an oligonucleotide sequence; e) mixing the portion with nucleic acid amplification reagents; f) amplifying the oligonucleotide sequence; and g) detecting amplified nucleic acid. The invention also provides a kit for use with the method for detection of at least one analyte derived from a sample.

First claim

We claim:

1. A method for detection of at least one analyte derived from a sample, comprising the steps of:
a) depositing the sample on a surface of a solid support, drying the sample on the surface of the solid support, and storing the dried sample on the solid support at ambient temperature for at least one month;
b) transferring at least a portion of the solid support and the dried sample to a receptacle suitable for performing a specific binding assay for one or more analytes of interest;
c) washing the said portion for at least 3 minutes;
d) adding a single specific binding partner for each analyte of interest to said receptacle said binding partner being labelled with an oligonucleotide sequence;
e) mixing said portion with nucleic acid amplification reagents;
f) amplifying the oligonucleotide sequence; and
g) detecting amplified nucleic acid,
wherein the solid support comprises cellulose based paper, or woven or non-woven fibrous materials,
wherein more than one analytes are individually detected simultaneously by detecting the amplified nucleic acid sequence associated with each specific binding partner, each labelled with a unique oligonucleotide sequence, and
wherein the binding partners and the nucleic acid amplification reagents are provided in ambient temperature stable, dried form.

2. The method of claim 1 , further comprising:
quantifying the analyte of interest based on the quantity of amplified nucleic acid.

3. The method of claim 1 , wherein the solid support comprises man made, or naturally occurring polymer fibres, or mineral fibre based materials all provided with a surface micro roughness of sufficient roughness to be held with a holder.

4. The method of claim 1 , wherein the solid support surface is impregnated with at least one of a weak base, a chelating agent, an anionic surfactant, or an anti-oxidant.

5. The method of claim 1 , wherein the solid support surface is impregnated with a chaotrope.

6. The method of claim 1 , wherein the solid support is a surfactant- treated cellulose based solid support.

7. The method of claim 1 , wherein the adding and mixing steps are performed in the presence of a sequestrant to counteract surfactant inhibition of enzyme activity or binding of the specific binding partner.

8. The method of claim 7 , wherein the sequestrant is a cyclodextrin.

9. The method of claim 1 , wherein the solid support is coated with specific binding moieties, or, surface charge modifying agents.

10. The method of claim 1 , wherein the specific binding partner is an antibody.

11. The method of claim 1 , wherein the specific binding partner is an aptamer.

12. The method of claim 1 , wherein the specific binding partner is a natural or recombinant protein.

13. The method of claim 1 , wherein the specific binding partner is a recombinant Pleckstrin homology domain, FYVE domain, PX domain, ENTH domain, CALM domain, PDZ domains, PTB domains, FERM domain or Metallothioneins.

14. The method of claim 1 , wherein the sample is derived from a biological sample.

15. The method according to claim 1 , wherein the sample comprises one or more of a drug, pollutants, herbicides, pesticides, or metals.

16. The method of claim 1 , wherein the sample is derived from a crime scene, wherein the sample comprises blood, semen, hair roots, fibres, alcohol, drugs of abuse, explosives or gunpowder, and wherein the sample is configured to be used for forensics purposes.

17. The method of claim 1 , wherein the nucleic acid amplification reaction comprises polymerase chain reaction.

18. The method of claim 1 , wherein the nucleic acid amplification reaction comprises isothermal amplification.

19. The method of claim 18 wherein the isothermal amplification reaction comprises rolling circle amplification.

20. The method of claim 19 , wherein the amplification product is measured by a hybridisation reaction.

Assignees

• Ge Healthcare Uk Ltd
• Global Life Sciences Solutions Operations UK Ltd

Inventors

• Lamerton Kathryn Louise
• Horton Jeffrey Kenneth
• Tatnell Peter James

Classifications

• G01N2458/10

  Oligonucleotides as tagging agents for labelling antibodies · CPC title

• C12Q1/6804 Primary

  Nucleic acid analysis using immunogens (immunoassay G01N33/53) · CPC title

• G01N33/54306

  Solid-phase reaction mechanisms · CPC title

• C12Q1/6851

  Quantitative amplification · CPC title

• C12Q2525/205

  Aptamer · CPC title